Foundry Partners LLC boosted its holdings in Prestige Consumer Healthcare Inc (NYSE:PBH) by 21.3% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 11,710 shares of the company’s stock after buying an additional 2,060 shares during the quarter. Foundry Partners LLC’s holdings in Prestige Consumer Healthcare were worth $371,000 at the end of the most recent quarter.
A number of other large investors have also bought and sold shares of PBH. Financial Gravity Wealth Inc. acquired a new stake in Prestige Consumer Healthcare in the first quarter valued at about $50,000. Quadrant Capital Group LLC increased its stake in shares of Prestige Consumer Healthcare by 2,979.3% during the 1st quarter. Quadrant Capital Group LLC now owns 1,786 shares of the company’s stock worth $53,000 after purchasing an additional 1,728 shares in the last quarter. Bailard Inc. purchased a new position in shares of Prestige Consumer Healthcare during the 1st quarter worth approximately $245,000. Diversified Trust Co increased its stake in shares of Prestige Consumer Healthcare by 8.2% during the 2nd quarter. Diversified Trust Co now owns 8,575 shares of the company’s stock worth $272,000 after purchasing an additional 650 shares in the last quarter. Finally, Citigroup Inc. increased its stake in shares of Prestige Consumer Healthcare by 72.2% during the 4th quarter. Citigroup Inc. now owns 9,271 shares of the company’s stock worth $286,000 after purchasing an additional 3,887 shares in the last quarter.
PBH opened at $32.44 on Thursday. The business has a 50-day moving average of $32.40. The company has a market cap of $1.74 billion, a P/E ratio of 11.67, a P/E/G ratio of 1.85 and a beta of 0.91. Prestige Consumer Healthcare Inc has a 1-year low of $26.25 and a 1-year high of $41.76. The company has a debt-to-equity ratio of 1.63, a current ratio of 2.16 and a quick ratio of 1.26.
Prestige Consumer Healthcare (NYSE:PBH) last released its earnings results on Thursday, August 1st. The company reported $0.65 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.64 by $0.01. Prestige Consumer Healthcare had a negative net margin of 3.81% and a positive return on equity of 12.45%. The company had revenue of $232.15 million during the quarter, compared to the consensus estimate of $231.52 million. During the same quarter in the previous year, the firm earned $0.68 EPS. The company’s revenue was down 8.6% on a year-over-year basis. As a group, sell-side analysts expect that Prestige Consumer Healthcare Inc will post 2.82 earnings per share for the current year.
PBH has been the subject of several recent analyst reports. ValuEngine raised shares of Prestige Consumer Healthcare from a “strong sell” rating to a “sell” rating in a research note on Friday, July 26th. TheStreet upgraded…